EVC
Basic information
Region (hg38): 4:5711201-5814305
Links
Phenotypes
GenCC
Source:
- Ellis-van Creveld syndrome (Definitive), mode of inheritance: AR
- acrofacial dysostosis, Weyers type (Definitive), mode of inheritance: AR
- Ellis-van Creveld syndrome (Supportive), mode of inheritance: AR
- acrofacial dysostosis, Weyers type (Supportive), mode of inheritance: AD
- acrofacial dysostosis, Weyers type (Limited), mode of inheritance: Unknown
- Ellis-van Creveld syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ellis-van Creveld syndrome | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Dental; Dermatologic; Musculoskeletal | 7628126; 10700184; 17024374; 18454448; 18947413; 19744229; 20184732; 23220543 |
ClinVar
This is a list of variants' phenotypes submitted to
- Ellis-van Creveld syndrome;Curry-Hall syndrome (66 variants)
- Curry-Hall syndrome;Ellis-van Creveld syndrome (52 variants)
- Ellis-van Creveld syndrome (19 variants)
- not provided (9 variants)
- EVC-related disorder (2 variants)
- Short-rib thoracic dysplasia 6 with or without polydactyly (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EVC gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 500 | 12 | 515 | |||
missense | 253 | 21 | 14 | 290 | ||
nonsense | 49 | 18 | 67 | |||
start loss | 6 | |||||
frameshift | 66 | 54 | 126 | |||
inframe indel | 23 | 24 | ||||
splice donor/acceptor (+/-2bp) | 46 | 52 | ||||
splice region | 1 | 2 | 11 | 81 | 7 | 102 |
non coding | 94 | 277 | 142 | 514 | ||
Total | 123 | 126 | 379 | 798 | 168 |
Highest pathogenic variant AF is 0.000112
Variants in EVC
This is a list of pathogenic ClinVar variants found in the EVC region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-5711218-G-A | Ellis-van Creveld syndrome | Uncertain significance (Jan 12, 2018) | ||
4-5711242-G-A | Ellis-van Creveld syndrome | Uncertain significance (Jan 13, 2018) | ||
4-5711242-GGA-G | Ellis-van Creveld syndrome • Curry-Hall syndrome | Uncertain significance (Jun 14, 2016) | ||
4-5711345-G-A | Ellis-van Creveld syndrome | Uncertain significance (Jan 12, 2018) | ||
4-5711345-GC-AA | not specified | Likely benign (Feb 27, 2018) | ||
4-5711346-C-A | Ellis-van Creveld syndrome | Uncertain significance (Jan 13, 2018) | ||
4-5711351-TGCGGCGGGGCGGCAGCCTGAGCGCCCCGGATGGCCC-T | Curry-Hall syndrome;Ellis-van Creveld syndrome | Likely pathogenic (Sep 13, 2022) | ||
4-5711361-C-A | Ellis-van Creveld syndrome | Uncertain significance (Jan 13, 2018) | ||
4-5711380-GA-TT | Curry-Hall syndrome;Ellis-van Creveld syndrome | Pathogenic (Oct 25, 2022) | ||
4-5711381-A-C | Curry-Hall syndrome;Ellis-van Creveld syndrome | Pathogenic (May 28, 2023) | ||
4-5711381-A-G | Curry-Hall syndrome;Ellis-van Creveld syndrome | Likely pathogenic (Apr 09, 2022) | ||
4-5711382-T-A | Ellis-van Creveld syndrome • Ellis-van Creveld syndrome;Curry-Hall syndrome | Pathogenic/Likely pathogenic (Dec 03, 2021) | ||
4-5711382-T-C | Curry-Hall syndrome;Ellis-van Creveld syndrome | Likely pathogenic (Dec 31, 2021) | ||
4-5711383-G-GTATAAGAGACA | Ellis-van Creveld syndrome | Likely pathogenic (Dec 17, 2021) | ||
4-5711388-G-C | not specified • Curry-Hall syndrome;Ellis-van Creveld syndrome • Ellis-van Creveld syndrome • Inborn genetic diseases • EVC-related disorder | Conflicting classifications of pathogenicity (Jul 02, 2024) | ||
4-5711389-C-A | Ellis-van Creveld syndrome;Curry-Hall syndrome | Likely benign (Jun 30, 2021) | ||
4-5711388-G-GTGCTGCTGAGTGT | Ellis-van Creveld syndrome | Likely pathogenic (Mar 23, 2022) | ||
4-5711392-CG-C | Ellis-van Creveld syndrome;Curry-Hall syndrome | Pathogenic (Sep 25, 2021) | ||
4-5711394-G-T | Curry-Hall syndrome;Ellis-van Creveld syndrome | Likely benign (Dec 19, 2023) | ||
4-5711393-G-GCTCA | Ellis-van Creveld syndrome | Likely pathogenic (Mar 18, 2022) | ||
4-5711401-C-G | Ellis-van Creveld syndrome;Curry-Hall syndrome | Likely benign (Nov 06, 2023) | ||
4-5711403-GC-G | Ellis-van Creveld syndrome • Curry-Hall syndrome;Ellis-van Creveld syndrome | Pathogenic/Likely pathogenic (Mar 31, 2023) | ||
4-5711404-C-T | Curry-Hall syndrome;Ellis-van Creveld syndrome | Likely benign (Nov 09, 2023) | ||
4-5711404-CA-C | Ellis-van Creveld syndrome | Likely pathogenic (Dec 30, 2021) | ||
4-5711405-A-T | Curry-Hall syndrome;Ellis-van Creveld syndrome | Pathogenic (Nov 13, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EVC | protein_coding | protein_coding | ENST00000382674 | 21 | 117849 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.46e-25 | 0.0133 | 125639 | 0 | 109 | 125748 | 0.000434 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.25 | 598 | 518 | 1.16 | 0.0000341 | 6398 |
Missense in Polyphen | 157 | 130.02 | 1.2075 | 1653 | ||
Synonymous | -2.42 | 278 | 231 | 1.20 | 0.0000168 | 1979 |
Loss of Function | 1.17 | 43 | 52.1 | 0.825 | 0.00000265 | 598 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000769 | 0.000767 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000382 | 0.000381 |
Finnish | 0.000277 | 0.000277 |
European (Non-Finnish) | 0.000513 | 0.000510 |
Middle Eastern | 0.000382 | 0.000381 |
South Asian | 0.000360 | 0.000359 |
Other | 0.000820 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the EvC complex that positively regulates ciliary Hedgehog (Hh) signaling. Involved in endochondral growth and skeletal development. {ECO:0000250|UniProtKB:P57680}.;
- Disease
- DISEASE: Acrofacial dysostosis, Weyers type (WAD) [MIM:193530]: An autosomal dominant condition characterized by dysplastic nails, postaxial polydactyly, dental anomalies, short limbs, short stature and normal intelligence. The phenotype is milder than Ellis-van Creveld syndrome. {ECO:0000269|PubMed:10700184}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Hedgehog signaling pathway - Homo sapiens (human);Hedgehog Signaling Pathway;Signal Transduction;Activation of SMO;Hedgehog ,on, state;Signaling by Hedgehog
(Consensus)
Recessive Scores
- pRec
- 0.180
Intolerance Scores
- loftool
- 0.832
- rvis_EVS
- 3.73
- rvis_percentile_EVS
- 99.58
Haploinsufficiency Scores
- pHI
- 0.127
- hipred
- N
- hipred_score
- 0.270
- ghis
- 0.434
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.157
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Evc
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; limbs/digits/tail phenotype; craniofacial phenotype; growth/size/body region phenotype; cellular phenotype;
Gene ontology
- Biological process
- skeletal system development;endochondral bone growth;smoothened signaling pathway;muscle organ development;positive regulation of smoothened signaling pathway;cartilage development
- Cellular component
- cytoplasm;cilium;integral component of membrane;ciliary basal body;ciliary membrane;plasma membrane protein complex
- Molecular function